Search

Author/Creator Tu, Chuanqing

1. De‐escalation or discontinuation of tyrosine kinase inhibitor in patients with chronic myeloid leukemia: A multicentral, open‐label, prospective trial in China. Issue 4 (19th September 2022)

Authors:
Luo, Jie; Du, Xin; Lou, Jin; Wu, Jianwei; Ma, Liping; Huang, Jixian; Wang, Liangtuo; Tu, Chuanqing; Liu, Zelin; Chen, Liya; Tan, Yaxian; Luo, Dongmei; Liang, Hanyin; Yin, Changxin; Cao, Rui; Zhou, Xuan; Liu, Qifa; Liu, Xiaoli; Xu, Na
Journal:
EJHaem
Issue:
Volume 3:Issue 4(2022)
Page Start:
1220
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. SDF-1α Facilitates Mesenchymal Stem Cells to Induce Regulatory B Cell Differentiation from Patients with Immune Thrombocytopenia. (8th November 2021)

Authors:
Chen, Zhe; Zhou, Shufen; Li, Jianyun; Li, Hui; Huang, Can; Guo, Qin; Zhang, Tiantian; Yang, Bingya; Tu, Chuanqing; Guo, Chengshan
Other Names:
Zhang Dunfang Academic Editor.
Journal:
Stem cells international
Issue:
Volume 2021(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search